FGF-23 AND ENDOCRINE-METABOLIC ALTERATIONS IN KIDNEY TRANSPLANT RECIPIENTS AND HEMODIALYSIS PATIENTS
To compare circulating fibroblast growth factor 23 (FGF-23), renal function and glucose metabolism markers between kidney transplant recipients and patients receiving maintenance hemodialysis.
Authors
- Komiljonova O.O.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-12
- DOI
- https://doi.org/10.5281/zenodo.24149584
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00